Next Article in Journal
Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study
Next Article in Special Issue
Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review
Previous Article in Journal
Advancements in Microfluidic Cassette-Based iMiDEV™ Technology for Production of L-[11C]Methionine and [11C]Choline
Previous Article in Special Issue
Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events
 
 
Review

Article Versions Notes

Pharmaceuticals 2024, 17(2), 252; https://doi.org/10.3390/ph17020252
Action Date Notes Link
article xml file uploaded 15 February 2024 14:47 CET Original file -
article xml uploaded. 15 February 2024 14:47 CET Update https://www.mdpi.com/1424-8247/17/2/252/xml
article pdf uploaded. 15 February 2024 14:47 CET Version of Record https://www.mdpi.com/1424-8247/17/2/252/pdf
article html file updated 15 February 2024 14:48 CET Original file https://www.mdpi.com/1424-8247/17/2/252/html
Back to TopTop